THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Dwight Reynolds to Aged

Back to Details
This is a "connection" page, showing publications Dwight Reynolds has written about Aged.
Dwight Reynolds
Connection Strength
0.877
Aged
  1. Impact of operator experience and training strategy on procedural outcomes with leadless pacing: Insights from the Micra Transcatheter Pacing Study. Pacing Clin Electrophysiol. 2017 Jul; 40(7):834-842.
    View in: PubMed
    Score: 0.072
  2. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Electrophysiol. 2017 Jun; 28(6):659-665.
    View in: PubMed
    Score: 0.071
  3. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 2016 Feb 11; 374(6):533-41.
    View in: PubMed
    Score: 0.064
  4. Apparent acute reversible right ventricular pacing-induced left ventricular dysfunction. J Cardiovasc Electrophysiol. 2013 Feb; 24(2):224-6.
    View in: PubMed
    Score: 0.052
  5. Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF. J Natl Med Assoc. 2012 May-Jun; 104(5-6):287-98.
    View in: PubMed
    Score: 0.050
  6. Prevention of cardiovascular events by treating hypertension in older adults: an evidence-based approach. J Clin Hypertens (Greenwich). 2008 Mar; 10(3):219-25.
    View in: PubMed
    Score: 0.038
  7. Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing. Europace. 2019 Nov 01; 21(11):1686-1693.
    View in: PubMed
    Score: 0.021
  8. Incidence and outcomes of systemic infections in patients with leadless pacemakers: Data from the Micra IDE study. Pacing Clin Electrophysiol. 2019 08; 42(8):1105-1110.
    View in: PubMed
    Score: 0.021
  9. Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra postapproval registry. J Cardiovasc Electrophysiol. 2019 04; 30(4):569-574.
    View in: PubMed
    Score: 0.020
  10. Health-related quality of life impact of a transcatheter pacing system. J Cardiovasc Electrophysiol. 2018 12; 29(12):1697-1704.
    View in: PubMed
    Score: 0.020
  11. Physical activity detection in patients with intracardiac leadless pacemaker. J Cardiovasc Electrophysiol. 2018 12; 29(12):1690-1696.
    View in: PubMed
    Score: 0.020
  12. To retrieve, or not to retrieve: System revisions with the Micra transcatheter pacemaker. Heart Rhythm. 2017 12; 14(12):1801-1806.
    View in: PubMed
    Score: 0.018
  13. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017 Mar 07; 38(10):730-738.
    View in: PubMed
    Score: 0.018
  14. Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017 05; 14(5):702-709.
    View in: PubMed
    Score: 0.018
  15. Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial. Heart Rhythm. 2017 05; 14(5):685-691.
    View in: PubMed
    Score: 0.017
  16. Rate adaptive pacing in an intracardiac pacemaker. Heart Rhythm. 2017 02; 14(2):200-205.
    View in: PubMed
    Score: 0.017
  17. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide. J Cardiovasc Electrophysiol. 2016 07; 27(7):827-32.
    View in: PubMed
    Score: 0.017
  18. Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J. 2015 Oct 01; 36(37):2510-9.
    View in: PubMed
    Score: 0.016
  19. Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry. J Am Coll Cardiol. 2014 Aug 26; 64(8):797-807.
    View in: PubMed
    Score: 0.015
  20. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. Circ Heart Fail. 2014 Jan; 7(1):146-53.
    View in: PubMed
    Score: 0.014
  21. The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): quality of life and psychological functioning in patients receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2014 Jan; 25(1):43-51.
    View in: PubMed
    Score: 0.014
  22. The right atrial free wall: an alternative pacing site. Pacing Clin Electrophysiol. 1993 May; 16(5 Pt 1):959-63.
    View in: PubMed
    Score: 0.014
  23. Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF. Pacing Clin Electrophysiol. 2013 Apr; 36(4):433-43.
    View in: PubMed
    Score: 0.013
  24. B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF. J Cardiovasc Med (Hagerstown). 2012 Jun; 13(6):360-7.
    View in: PubMed
    Score: 0.013
  25. Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices. Clin Cardiol. 2012 Mar; 35(3):187-96.
    View in: PubMed
    Score: 0.012
  26. Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J. 2012 Jan; 163(1):49-56.e2.
    View in: PubMed
    Score: 0.012
  27. Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients. Pacing Clin Electrophysiol. 2012 Feb; 35(2):135-45.
    View in: PubMed
    Score: 0.012
  28. Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. Congest Heart Fail. 2012 Jan-Feb; 18(1):9-17.
    View in: PubMed
    Score: 0.012
  29. Associations between outpatient heart failure process-of-care measures and mortality. Circulation. 2011 Apr 19; 123(15):1601-10.
    View in: PubMed
    Score: 0.012
  30. patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial). Am J Cardiol. 2011 Jan 15; 107(2):250-8.
    View in: PubMed
    Score: 0.012
  31. Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF. J Card Fail. 2010 Dec; 16(12):940-9.
    View in: PubMed
    Score: 0.011
  32. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010 Aug 10; 122(6):585-96.
    View in: PubMed
    Score: 0.011
  33. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail. 2010 Sep; 3(5):596-605.
    View in: PubMed
    Score: 0.011
  34. Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). Am J Cardiol. 2010 Jun 15; 105(12):1773-9.
    View in: PubMed
    Score: 0.011
  35. Electronic health records and quality of care for heart failure. Am Heart J. 2010 Apr; 159(4):635-642.e1.
    View in: PubMed
    Score: 0.011
  36. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Am J Cardiol. 2010 Apr 15; 105(8):1140-6.
    View in: PubMed
    Score: 0.011
  37. Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Am Heart J. 2010 Feb; 159(2):238-44.
    View in: PubMed
    Score: 0.011
  38. Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). Am J Cardiol. 2010 Jan 15; 105(2):255-60.
    View in: PubMed
    Score: 0.011
  39. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009 Dec; 158(6):956-64.
    View in: PubMed
    Score: 0.011
  40. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm. 2009 Dec; 6(12):1727-34.
    View in: PubMed
    Score: 0.010
  41. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J. 2009 Apr; 157(4):754-62.e2.
    View in: PubMed
    Score: 0.010
  42. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail. 2008 Jul; 1(2):98-106.
    View in: PubMed
    Score: 0.010
  43. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003 Feb 19; 41(4):565-71.
    View in: PubMed
    Score: 0.007
  44. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail. 2002 Apr; 8(2):63-70.
    View in: PubMed
    Score: 0.006
  45. Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. J Cardiovasc Electrophysiol. 2002 Feb; 13(2):144-50.
    View in: PubMed
    Score: 0.006
  46. Interference with cardiac pacemakers by cellular telephones. N Engl J Med. 1997 May 22; 336(21):1473-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES